medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
101条
与
Tumor
有关的结果
Families with BAP1-tumor Predisposition Syndrome in the Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines
2019年 发布于
Cancers (Basel)
11卷 第8期
所属人体系统:
其他
|
诊断/检测/评估方法
无
BAP1
BAP1
Tumor
Predisposition Syndrome
Germline
Referral Guidelines.
指南简介
原文链接
Diagnostik, Therapie Und Nachsorge Maligner Ovarialtumoren. S3-LL (Leitlinienprogramm Onkologie Von AWMF, DKG Und DKH)(English Title Translation: Diagnosis, Treatment and Aftercare of Malignant Tumors of the Ovary)
2019年
所属人体系统:
生殖
|
卵巢肿瘤
Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften
Malignant
Tumor
s of the Ovary
Diagnostics
Therapy
Aftercare
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
生殖
|
卵巢肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of
Tumor
Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic
Tumor
Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No
Tumor
Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative
Tumor
Residue Or in FIGO Stage IV
Tumor
s
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
生殖
|
卵巢肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of
Tumor
Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic
Tumor
Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No
Tumor
Residue (grade B).
指南简介
原文链接
Management of Epilepsy in Brain Tumors
2019年 发布于
Neurol Sci
40卷 第10期
所属人体系统:
其他
|
头颈部肿瘤
Brain Tumor-related Epilepsy Study Group of Italian League Against Epilepsy
Antiepileptic Drugs
Brain
Tumor
s
Epilepsy
Interaction
Quality of Life
Side Effect
指南简介
原文链接
Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines
2019年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统:
其他
|
头颈部肿瘤
American Society of Clinical Oncology
Metastatic Brain
Tumor
s
Anticonvulsant Prophylaxis
Steroid
指南简介
原文链接
SIU-ICUD Consultation on Bladder Cancer: Treatment of Muscle-invasive Bladder Cancer
2019年 发布于
World J Urol
37卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
无
Adjuvant Chemotherapy
Bladder-sparing
Chemoradiation
Enhanced Recovery after Surgery
Muscle-invasive Bladder Cancer
Neoadjuvant Chemotherapy
Radical Cystectomy
Transurethral Resection of Bladder
Tumor
Trimodal
Urothelial Carcinoma of Bladder
Variant Histology
指南简介
原文链接
Diagnostik, Therapie Und Nachsorge Der Keimzelltumoren Des Hodens. S3-LL (Leitlinienprogramm Onkologie Von AWMF, DKG Und DKH)(English Title Translation: Diagnostics, Therapy and Aftercare of the Germ Cell Tumors of the Testis)
2019年
所属人体系统:
生殖
|
睾丸肿瘤
Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften
Germ Cell
Tumor
s of the Testis
Diagnostics
Therapy
Aftercare
指南简介
原文链接
Minimally Invasive Surgery in Pediatric Oncology: Proposal of Guidelines
2019年 发布于
Anticancer Res
39卷 第11期
所属人体系统:
其他
|
治疗方案
无
Minimally Invasive Surgery
Wilms
Tumor
Lung Metastases
Neuroblastoma
Ovarian
Tumor
Pediatric Oncology
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of
Tumor
Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic
Tumor
Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No
Tumor
Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative
Tumor
Residue Or in FIGO Stage IV
Tumor
s
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of
Tumor
Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic
Tumor
Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No
Tumor
Residue (grade B).
指南简介
原文链接
Management of Asymptomatic, Well-differentiated PNETs: Results of the Delphi Consensus Process of the Americas Hepato-Pancreato-Biliary Association
2019年 发布于
HPB (Oxford)
21卷 第5期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
Americas Hepato-Pancreato-Biliary Association
Nonmetastatic Pancreatic Neuroendocrine
Tumor
s
PNETs
Management
Consensus
指南简介
原文链接
SEOM Clinical Guidelines for the Diagnosis and Treatment of Gastroenteropancreatic and Bronchial Neuroendocrine Neoplasms (NENs) (2018)
2019年 发布于
Clin Transl Oncol
21卷 第1期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
Spanish Society of Medical Oncology
Diagnosis
Gastroenteropancreatic
Guidelines
Lung
Neuroendocrine Neoplasms
Neuroendocrine
Tumor
s
Therapy
指南简介
原文链接
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients with Lung Neuroendocrine Tumors: an International Collaborative Endorsement and Update of
2020年 发布于
Journal of Thoracic Oncology
15卷 第10期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
Commonwealth Neuroendocrine Tumour Research Collaboration
North American Neuroendocrine Tumor Society
Bronchial Neuroendocrine
Tumor
s/tumours
Consensus Statements
Guidelines
Lung Carcinoids
Lung Neuroendocrine
Tumor
s/tumours.
指南简介
原文链接
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors
2020年 发布于
Pancreas
49卷 第1期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
North American Neuroendocrine Tumor Society
Pancreatic
Neuroendocrine
Tumor
s
Surgical Management
Consensus
指南简介
原文链接
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
2020年 发布于
Pancreas
49卷 第7期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
North American Neuroendocrine Tumor Society
Pancreatic
Neuroendocrine
Tumor
s
Surveillance
Management
Consensus
指南简介
原文链接
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors
2020年 发布于
Cancer
126卷 第11期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
Chicago Consensus Working Group
Consensus
Neoplasm Metastasis
Neuroendocrine
Tumor
s
Peritoneal Neoplasms.
指南简介
原文链接
Treatment Guidelines for Pancreatic Neuroendocrine Tumors (except Peptide Receptor Radionuclide Therapy)
2020年 发布于
Correspondances En Metabolismes Hormones Diabetes Et Nutrition
24卷 第4,5期
所属人体系统:
神经
、
内分泌
|
神经内分泌肿瘤
无
Pancreatic Neuroendocrine
Tumor
s
Treatment of Hormone-excess States
Antitumor Treatment
指南简介
原文链接
Japan Society of Clinical Oncology Provisional Clinical Opinion for the Diagnosis and Use of Immunotherapy in Patients with Deficient DNA Mismatch Repair Tumors, Cooperated by Japanese Society of Medical Oncology, First Edition
2020年 发布于
Int J Clin Oncol
25卷 第2期
所属人体系统:
其他
|
治疗方案
Japan Society of Clinical Oncology
Japanese Society of Medical Oncology
MSI-H
Mismatch Repair-deficient Advanced Solid
Tumor
PD-1/PD-L1 Inhibitor
Provisional Clinical Opinion
DMMR.
指南简介
原文链接
Expert Consensus on Assessing Tumor Response to Immune Checkpoint Inhibitors by PET/CT (2020 Edition)
2020年 发布于
Zhonghua Zhong Liu Za Zhi
42卷 第9期
所属人体系统:
其他
|
治疗方案
PET Group
Chinese Society of Nuclear Medicine
Expert Consensus
Immune Checkpoint
Malignant
Tumor
PET/CT.
指南简介
原文链接
首页
上一页
1
2
3
4
5
6
下一页
尾页
共101条,每页显示
20条
50条
100条
跳转至第
页
确定